MedTrace Logo

MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry

NCT06804148 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-02-03

No results posted yet for this study

Summary

Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.

Conditions

  • Aortic Valve Stenosis

Interventions

DEVICE

Myval Transcatheter Heart Valve

The Myval TAVR bioprothesis is a balloon-expandable THV developed by Meril Lifesciences, which has novel operator friendly design features to improve deliverability and aid precise deployment.

Sponsors & Collaborators

  • Prof. Dr. med. Ingo Eitel

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2030-12-01
Completion
2030-12-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06804148 on ClinicalTrials.gov